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Introduction: The incidence of delayed 
graft function (DGF) and unsatisfactory 
creatinine clearance (UCC) after renal 
transplantation is significantly higher 
in Brazil, when compared with that 
observed in United States or Europe. 
Deceased donor (DD) characteristics 
should directly influence the occurrence 
of these two outcomes. Objective: This 
study aim to evaluate the influence of 
DD characteristics on DGF and UCC 
incidence in Brazil. Methods: DD clini-
cal and laboratory variables were cor-
related with outcome's incidence. 
Results: We evaluated 787 DD whose or-
gans were transplanted in 1298 patients. 
We noted a high prevalence of vasoac-
tive drugs use (90.2%), hypernatremia 
(66.6%) and renal dysfunction (34.8%). 
The incidence of DGF and UCC was 
60.6% and 55.2%, respectively. We 
observed a progressive increase in DGF 
risk for age groups over 30 years and for 
cold ischemia time (CIT) greater than 24 
hours. DGF risk was two times higher in 
recipients of donor kidney final serum 
creatinine (Cr) over than 1.5 mg/dl. Hy-
pertension and CIT over 36 hours was 
associated with an increasing of 82% 
and 99% in UCC risk, respectively. Do-
nor age above 40 years was associated 
with a progressive increase in UCC risk. 
Conclusion: DD age, renal function, 
hypertension and prolonged CIT were 
associated with increased risk DGF and 
UCC.
AbstrAct
Keywords: creatinine, delayed graft function, 
donor selection, kidney transplantation.
IntroductIon
The need to increase the supply of kidneys 
for transplantation because of the high 
number of patients registered on the waiting 
list has demanded a more widespread use 
of organs from borderline deceased donors, 
which were previously discarded.1,2 Since 
the superiority of renal transplantation 
compared to dialysis was proven, it became 
necessary to use these organs.3-6
However, the increased use of borderline 
kidneys from deceased donors has been 
associated with an increased incidence 
of complications after transplantation, 
among them: delayed graft function 
(DGF), which occurs when there is a need 
for renal replacement therapy in the first 
week after transplantation, and poor 
kidney function (PKF), defined as serum 
creatinine above 1.5 mg/dL six months or 
one year after the transplant.2,7
The negative association between 
DGF and PKF and graft survival is well 
established. DGF patients have lower 
survival, lower graft function after 
recovery and higher incidence of acute 
rejection.8 Unsatisfactory renal function 
six months after transplantation was 
associated with a relative risk for graft 
loss being twice the risk of patients with 
serum creatinine lower than this value.9,10
For these reasons, it is necessary to 
identify the risk factors for DGF and 
PKF in order to develop interventions to 
reduce the occurrence of these outcomes 
and prevent complications.
Characteristics related to the deceased 
donor leading to higher incidences of 
these two outcomes have been thoroughly 
investigated.11 Factors related to hemody-
namic and electrolytic maintenance prior 
to multiple organ extraction, in addi-
tion to demographic characteristics, are 
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associated with increased risk for the development of 
DGF and PKF.9,12-15
In Brazil, the incidence of DGF is significantly 
higher than the U.S. incidence (57.3% vs. 23.5%),2,16 
and there is a lower graft survival after one year of the 
transplant.1,2 We still need to investigate the factors 
related to the deceased donor that determine a worse 
outcome of kidney transplantation in this country.
This study aimed at assessing the characteristics 
of deceased donors, associated with the incidence of 
DGF and PKF in a large transplant center in Brazil.
Methods
This is a retrospective study using a sequential 
cohort of deceased donors identified by the Organs 
and Tissues Search Service of the Paulista School of 
Medicine (SPOT-EPM) from January 1998 through 
December 2008. This study was approved by the 
local Ethics in Research Committee.
We removed from this analysis those deceased 
donors whose kidneys were transplanted at another 
transplant center; recipients aged less than 18; second 
kidney transplant recipients and recipients of another 
organ combined. The characteristics of deceased 
donors were extracted from the “Information 
About the Deceased Donor” form, completed by the 
SPOT-EPM and transferred to the State Transplant 
Central. The data about the kidney transplant 
recipients was obtained from medical records.
The aim of the study was to identify deceased 
donor risk factors associated with the development 
of delayed graft function (DGF) or poor kidney 
function (PKF) six months after transplantation. 
DGF was defined as the need for dialysis during the 
first week after transplantation. PKF six months after 
transplantation was defined as creatinine clearance 
less than or equal to 50 ml/min/1.73m2, calculated 
using the Cockcroft-Gault.17 Follow-up loss was 
defined as the definitive transfer of the recipient for 
monitoring in another service. Graft loss was defined 
as return to dialysis or retransplantation.
StatiStical analySiS
The categorical variables were presented as absolute 
and relative frequencies and the numerical variables 
as means and standard deviations. To analyze the PKF 
outcome in the sixth month we used an imputation 
method for missing values, as follows: (1) those 
patients who lost the graft before the sixth month we-
re assigned a value of zero for creatinine clearance; (2) 
for patients who died or lost the follow-up we used 
the last reading made (creatinine) (“Last observation 
carried Forward”) for the calculation of creatinine 
clearance in the sixth month.
The characteristics of the deceased donor assessed 
against the outcomes were: age, gender, ethnicity, 
cause of brain death, hypertension, diabetes mellitus, 
active infection, use of vasoactive drugs, length of 
stay in the intensive care unit, cardiac arrest during 
hospitalization, serum creatinine on the day of 
assessment (creatinine final), glutamic oxaloacetic 
transaminase (GOT), glutamic pyruvic transaminase 
(GPT), creatine phosphokinase, serum sodium, 
serology for hepatitis B (HBsAg), serology for hepa-
titis C (anti-HCV) and cold ischemia time. The asso-
ciation between donor characteristics and DGF and 
PKF outcomes were assessed using the chi-square or 
Fisher’s exact test for categorical variables and the 
Student t-test for the continuous variables. In order 
to find the donor variables independently associated 
with the DGF and PKF outcomes, we used logistic 
regression. The adequacy of fit of this model was 
verified using the Hosmer and Lemeshow test. For all 
the statistical tests we used a significance level of 5%, 
with p < 0.05. We used the SPSS version 17.0 (SPSS 
Inc., Chicago, IL, USA) software used for analysis.
results
During the study period, we found 1,085 deceased 
donors whose kidneys were transplanted into 1,646 
recipients in our service. We excluded 298 donors 
whose kidneys were allocated to 223 recipients under 
the age of 18 years and 125 recipients of second or third 
kidney transplant. We then analyzed 787 deceased 
donors and 1,298 kidney transplant recipients.
The average age of deceased donors was 40.2 
years and stroke was the leading cause of death 
(54.9%). The donor maintenance parameters analysis 
shows that 90.2% received a vasoactive drug at 
the time of evaluation and 15% had had a cardiac 
arrest reversed (Table 1). In addition, 70% had 
hypernatremia (Na > 145 mEq/l); 66.6% had elevated 
creatinine phosphokinase and 34.8% had kidney 
failure (creatinine > 1.5 mg/dl) (data not shown). 
The kidneys were transplanted within a mean cold 
ischemia time of 23.2 (Table 1).
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Recipients had a mean age of 46.1 years; 80.4% had 
hypertension, and 13.8% had diabetes mellitus. The 
incidence of DGF was 60.6% and the incidence of PKF 
was 55.2%. The mean creatinine level was 1.6 mg/dl 
and creatinine clearance was 46.1 ml/min/1.73m2 in 
the sixth month of transplantation. The receiver 
survival rate was 93% and graft survival was 90.6% 
six months after transplantation (Table 2).
tAble 1 DemOgraphic, clinical anD labOratOrial  
 characteriSticS Of the DeceaSeD DOnOrS
Donor Total (n = 787)
Age, mean ± DP (years) 40.2 ± 14.9
Age range, n (%)
≤ 10 years 
11-20 years 
21-30 years 
31-40 years 
41-50 years 
51-60 years 
≥ 61 years
18 (2.3) 
78 (9.9) 
127 (16.1) 
134 (17.0) 
218 (27.7) 
159 (20.2) 
53 (6.8)
Gender, n (%)
Males 434 (55.1)
Females 353 (44.9)
Ethnicity, n (%)
Black 75 (9.5)
Not black 571 (72.6)
No information 141 (18.0)
Brain death cause, n (%)
Stroke 432 (54.9)
Head injury 315 (40.0)
Neoplasia 11 (1.4)
Anoxic encephalopathy 23 (3.0)
Others 6 (0.8)
Systemic arterial hypertension, n (%) 201 (25.6)
Diabetes Mellitus, n (%) 21 (2.7)
Final creatinine, mean ± SD (mg/dL) 1.5 ± 1.0
≤ 0.8 mg/dL 167 (23.0)
0.8-1.5 mg/dL 306 (42.2)
> 1.5 mg/dL 252 (34.8)
No information 62
Active infection, n (%) 245 (31.2)
Use of vasoactive drug, n (%) 710 (90.2)
Cardiac arrest, n (%) 118 (15.0)
B Hepatitis virus, n (%) 2 (0.2)
C Hepatitis virus, n (%) 2 (0.2)
Days in the ICU, mean ± SD 5.4 ± 4.4
Sodium, mean ± SD (mEq/L) 154.6 ± 15.4
TGO, mean ± SD (U) 107.1 ± 302.7
TGP, mean ± SD (U) 75.4 ± 159.3
CPK, mean ± SD (U/L) 1706 ± 4262
≤ 250 U/L 191 (33.6)
250-1000 U/L 186 (32.7)
> 1000 U/L 192 (33.7)
No information 218
TIF, mean ± SD (h) 23.2 ± 7.2
≤ 12h 
13-18h 
19-24h 
25-30h 
31-36h 
≥ 37h
49 (6.4) 
152 (19.6) 
255 (33.2) 
192 (24.9) 
94 (12.4) 
27 (3.5)
No information 18
 tAble 2 DemOgraphic, clinical anD labOratOrial  
 characteriSticS Of recipientS Of DeceaSeD  
 kiDney DOnOrS
Recipient Total (n = 1298)
Age, mean ± SD (years) 46.1 ± 12.1
Weight, mean ± SD (kg) 62.7 ± 13.7
Gender, n (%)
Males 729 (56.2)
Females 569 (43.8)
Ethnicity, n (%)
Black 138 (10.6)
Not Black 922 (71.0)
No information 238 (18.3)
Cause of CKD, n (%)
Diabetes 176 (13.6)
Hypertension 248 (19.1)
Glomerulonephritis 168 (12.9)
Undetermined 472 (36.4)
Others 234 (18.0)
Hypertension, n (%) 1044 (80.4)
Diabetes Mellitus, n (%) 179 (13.8)
B Hepatitis virus, n (%) 46 (3.5)
C Hepatitis virus, n (%) 172 (13.3)
Delayed graft function, n (%) 787 (60.6)
Creatinine (6 months), mean ± SD 
(mg/dl)
1.6 ± 0.7
Creatinine clearance (6 months), 
mean ± SD (ml/min/1.73 m2)
46.1 ± 23.7
Poor kidney function (6 months), 
n (%)
717 (55.2)
Graft loss, n (%) 122 (9.4)
Death, n (%) 91 (7)
Loss of follow up, n (%) 8 (0.6)
DelayeD graft functiOn (Dgf)
The patients who developed DGF received kidneys 
from donors with higher mean ages (41.5 vs. 38.3 
years, p < 0.001), higher final creatinine mean levels 
(1.6 vs. 1.3 mg/dl, p < 0.001) and longer mean cold 
ischemia time (23.9 vs. 22.2 hours, p < 0.001). The 
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 tAble 3 cOmpariSOn Of DemOgraphic, clinical anD labOratOrial characteriSticS Of DeceaSeD DOnOrS in   
 functiOn Of DevelOping Or nOt DelayeD graft functiOn (Dfg)
With DGF (n = 787) Without DGF (n = 511) p-value
Age, mean ± SD (years) 41.5 ± 14.3 38.3 ± 15.7 < 0.001
Gender, n (%) 0.459
Males 440 (55.9) 275 (53.8)
Females 347 (44.1) 236 (46.2)
Ethnicity, n (%) 0.445
Black 79 (10.0) 45 (8.8)
Not Black 575 (73.1) 367 (71.8)
No information 133 (16.9) 99 (19.4)
Brain death cause, n (%) 0.106
Stroke 453 (57.6) 259 (50.7)
Head injury 295 (37.5) 224 (43.8)
Neoplasia 12 (1.5) 7 (1.4)
Anoxic encephalopathy 23 (2.9) 15 (2.9)
Others 4 (0.5) 6 (1.2)
Arterial hypertension, n (%) 224 (28.5) 108 (21.1) 0.003
Diabetes Mellitus, n (%) 22 (2.8) 13 (2.5) 0.785
Active infection. n (%) 234 (31.8) 152 (30.3) 0.599
Use of vasoactive drugs, n (%) 694 (90.1) 458 (90.3) 0.904
Cardiac arrest, n (%) 118 (15.3) 74 (14.6) 0.721
B hepatitis virus, n (%) 3 (0.4) 0 (0.0) 0.162
C hepatitis virus, n (%) 2 (0.3) 0 (0.0) 0.522
ICU stay in days, mean ± SD 5.5 ± 4.5 5.2 ± 4.4 0.442
Sodium, mean ± SD (mEq/L) 155.3 ± 15.3 153.6 ± 15.6 0.085
TGO, mean ± SD (U) 110.9 ± 327.3 102.2 ± 267.9 0.662
TGP, mean ± SD (U) 74.7 ± 148.8 76.2 ± 172.1 0.884
CPK, mean ± SD (U/L) 1655 ± 3412 1772 ± 5160 0.676
Final creatinine, mean ± SD (mg/dL) 1.6 ± 1.1 1.3 ± 0.8 < 0.001
Cold ischemia time, mean ± SD (h) 23.9 ± 7.5 22.2 ± 6.8 < 0.001
rate of hypertensive donors was higher in the group 
with DGF (28.5% vs. 21.1%, p = 0.003), respectively 
(Table 3). After the logistic regression analysis with 
multiple variables, we observed a progressive increase 
in the risk of developing DGF from age greater than 30 
years, with the final creatinine valuesabove 1.5 mg/dl 
and cold ischemia times longer than 24 hours (Table 4).
pOOr kiDney functiOn Six mOnthS after kiDney 
tranSplantatiOn
Recipients with PKF in the sixth month after 
transplantation received kidneys from deceased donors 
with higher mean age (43.7 vs. 35.9 years, p < 0.001), 
with a higher number of females (49.1% vs. 39.8%, 
p = 0.001), non-black ethnicity (75.2% vs. 69.4%, 
p = 0.044), with stroke as a cause of brain death 
(60.8% vs. 47.5%, p < 0.001) and associated hyper-
tension (33.6% vs. 15.7%, p < 0.001). The mean cold 
ischemia time was almost one hour higher on the reci-
pients with PKF (23.6 vs. 22.7 hours, p = 0.028). On the 
other hand, CPK levels were higher in patients without 
PKF (1444.4 vs. 20005.5 U/l, p = 0.051) in the sixth 
semester of transplantation (Table 5). After logistic 
regression analysis with multiple variables, we observed 
a progressive increase in the risk of developing PKF from 
age greater than 40 years, with arterial hypertension and 
cold ischemia times greater than 36 hours (Table 6).
dIscussIon
The most important observation of this study was the 
high incidence of outcomes assessed. In our sample, 
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Variable
Univariate Multivariate
OR (CI 95%) p OR (CI 95%) p
Age range
≤ 10 years (ref.) 1.00 - 1.00 -
11-20 years 1.19 (0.4-3.7) 0.771 1.00 Ns
21-30 years 1.14 (0.4-3.5) 0.822 1.00 Ns
31-40 years 2.36 (0.8-7.2) 0.132 1.67 (1.2-2.4) 0.007
41-50 years 2.67 (0.9-8.0) 0.082 2.09 (1.5-2.9) < 0.001
51-60 years 2.18 (0.7-6.7) 0.172 1.68 (1.2-2.4) 0.004
≥ 61 years 2.23 (0.7-7.3) 0.186 1.70 (1.0-2.8) 0.037
Gender
Males 1.23 (0.9-1.7) 0.234
Females (ref.) 1.00 -
Ethnicity
Blacks 0.81 (0.5-1.3) 0.418
Not blacks (ref.) 1.00 -
No information 0.95 (0.7-1.4) 0.769
BD cause
Stroke (ref.) 1.00 -
Head injury 0.85 (0.6-1.3) 0.413
Neoplasia 1.16 (0.3-4.0) 0.818
Anoxic encephalitis 2.24 (0.8-6.4) 0.132
Others 1.57 (0.3-8.2) 0.589
Arterial Hypertension 1.22 (0.8-1.8) 0.289
Diabetes Mellitus 0.80 (0.4-1.7) 0.565
Final Cr 2.51
≤ 0.8 mg/dL (ref.) 1.00 -
0.8-1.5 mg/dL 1.18 (0.8-1.7) 0.399
> 1.5 mg/dL 2.51 (1.6-3.9) < 0.001 2.09 (1.6-2.7) < 0.001
Active infection 0.96 (0.7-1.3) 0.811
VAD use 1.04 (0.6-1.8) 0.898
Cardiac arrest 1.17 (0.7-1.8) 0.507
Days in the ICU 1.01 (1.0-1.0) 0.436
Sodium 1.01 (1.0-1.0) 0.268
TGO 1.00 (1.0-1.0) 0.563
TGP 1.00 (1.0-1.0) 0.535
CPK 1.00 (1.0-1.0) 0.436
TIF
≤ 12h (ref.) 1.00 - 1.00 -
13-18h 1.08 (0.4-2.8) 0.872 1.00 ns
19-24h 1.19 (0.5-3.0) 0.714 1.00 ns
25-30h 2.10 (0.8-5.4) 0.120 1.56 (1.2-2.0) 0.001
31-36h 1.60 (0.6-4.2) 0.341 5.10 (2.1-12.4) < 0.001
 tAble 4 riSk variableS aSSOciateD with DelayeD graft functiOn
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in which 22.7% of deceased donors were classified 
as extended, the incidence of DGF was 60.6%. This 
incidence is much higher than that in the U.S., in 
which 15.8% of the transplants were performed with 
kidneys from donors with cardiac arrest - a group of 
donors with worse outcomes.2 PKF incidence in this 
population was 55.2%; analyzing only the group of 
kidney recipients of expanded criteria donor, 70.9% 
had DGF. Comparing to the United States, where 
28.9% of recipients had creatinine clearance below 
60 ml/min six months after transplantation, this 
percentage is quite high.2
In fact, the high incidence of outcomes may have 
hindered the emergence of other characteristics asso-
ciated with hemodynamic maintaining of deceased 
donors as a risk factor for DGF and PKF. Furthermore, 
the high prevalence of laboratory abnormalities and 
severe hemodynamic disorders in this study popula-
tion, as described above, also masked the impact of 
other characteristics on outcomes. The average length 
of ICU stay until multiple organ extraction was 5 
days, 90% of them were using vasoactive drugs at the 
time of evaluation and 69% were being treated for an 
infection. The mean serum sodium was 156.1 mg/dl 
and creatinine was 1.5 mg/d, valueswhich were higher 
than normal reference ranges. This high incidence of 
outcomes and risk factors analyzed reflects the poor 
maintenance of deceased donors in Brazil.
In this study, age over 30 years, cold ischemia 
time greater than 24 hours and final creatinine above 
With PKF (n = 712) Without PKF (n = 581) p-value
Age, mean ± SD (years) 43.7 ± 14.5 35.9 ± 14.3 < 0.001
Age range, n (%)
Gender, n (%) 0.001
Males 365 (50.9) 350 (60.2)
Females 352 (49.1) 231 (39.8)
Ethnicity, n (%) 0.044
Black 66 (9.2) 58 (10.0)
Not black 539 (75.2) 403 (69.4)
No information 112 (15.6) 120 (20.7)
Brain death cause, n (%) < 0.001
Stroke 436 (60.8) 276 (47.5)
Head injury 242 (33.8) 277 (47.7)
Neoplasia 11 (1.5) 8 (1.4)
Anoxic encephalopathy 22 (3.1) 16 (2.8)
Others 6 (0.8) 4 (0.7)
Hypertension, n (%) 241 (33.6) 91 (15.7) < 0.001
Diabetes Mellitus, n (%) 22 (2.8) 13 (2.5) 0.358
Active infection, n (%) 217 (32.1) 169 (30.1) 0.443
Use of vasoactive drug, n (%) 637 (90.2) 515 (90.2) 0.984
Cardiac arrest, n (%) 108 (15.3) 84 (14.7) 0.813
HBV, n (%) 1 (0.1) 2 (0.3) 0.505
HCV, n (%) 2 (0.3) 0 (0.0) 0.505
Days in the ICU, mean ± SD 5.6 ± 4.5 5.1 ± 4.4 0.097
Sodium, mean ± SD (mEq/L) 153.9 ± 14.3 155.4 ± 16.6 0.122
TGO, mean ± SD(U) 100.3 ± 335.2 115.1 ± 260.2 0.451
TGP, mean ± SD(U) 71.8 ± 149.6 79.5 ± 169.9 0.459
CPK, mean ± SD (U/L) 1444 ± 3249 2005 ± 5169 0.051
Final creatinine, mean ± SD (mg/dL) 1.5 ± 1.0 1.5 ± 1.1 0.931
Cold ischemia duration, mean ± SD (h) 23.6 ± 7.3 22.7 ± 7.1 0.028
 tAble 5 cOmpariSOn Of DemOgraphic, clinical anD labOratOrial characteriSticS Of DeceaSeD DOnOrS in   
 functiOn Of the preSence Or abSence Of pOOr kiDney functiOn (pfk) in the Sixth mOnth Of tranSplant
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 tAble 6 riSk variableS aSSOciateD with pOOr kiDney functiOn
Variable
Univariate Multivariate
OR (CI 95%) p OR (CI 95%) p
Age range
≤ 10 years (ref.) 1.00 - 1.00 -
11-20 years 0.44 (0.1-1.3) 0.148 1.00 ns
21-30 years 0.56 (0.2-1.6) 0.291 1.00 ns
31-40 years 0.69 (0.2-2.0) 0.496 1.00 ns
41-50 years 1.07 (0.4-3.1) 0.897 1.84 (1.4-2.4) < 0.001
51-60 years 1.80 (0.6-5.3) 0.286 2.77 (2.0-3.9) < 0.001
≥ 61 years 2.72 (0.8-8.8) 0.095 3.84 (2.2-6.7) < 0.001
Gender
Males 0.82 (0.6-1.1) 0.235
Females (ref.) 1.00 -
Black ethnicity
Blacks 0.67 (0.4-1.1) 0.117
Not blacks (ref.) 1.00 -
No information 0.84 (0.6-1.2) 0.371
BD cause
Stroke (ref.) 1.00 -
Head injury 1.00 (0.7-1.5) 0.995
Neoplasia 1.00 (0.3-3.6) 0.995
Anoxic encephalopathy 2.07 (0.8-5.5) 0.147
Others 0.78 (0.2-4.2) 0.770
High blood pressure 2.14 (1.5-3.1) < 0.001 1.82 (1.4-2.5) < 0.001
Diabetes Mellitus 0.52 (0.2-1.2) 0.112
Final Cr 2.51
≤ 0.8 mg/dL (ref.) 1.00 -
0.8-.5 mg/dL 1.08 (0.7-1.6) 0.697
> 1.5 mg/dL 1.28 (0.8-2.0) 0.280
Active infection 0.91 (0.7-1.3) 0.564
Use of VAD 0.93 (0.5-1.6) 0.785
Cardiac arrest 1.08 (0.7-1.7) 0.746
Days in the ICU 1.02 (1.0-1.0) 0.270
Sodium 0.99 (1.0-1.0) 0.132
TGO 1.00 (1.0-1.0) 0.954
TGP 1.02 (1.0-1.0) 0.811
CPK 1.00 (1.0-1.0) 0.436
≤ 250 (ref.) 1.00 -
251-1000 0.91 (0.6-1.3) 0.620
> 1000 0.89 (0.6-1.3) 0.548
TIF
≤ 12h (ref.) 
13-18h 
19-24h 
25-30h 
31-36h 
> 37h
1.00 
1.13 (0.4-3.0) 
1.10 (0.4-2.9) 
1.27 (0.5-3.3) 
1.21 (0.4-3.3) 
4.03 (1.1-14.3)
- 
0.801 
0.849 
0.629 
0.713 
0.032
1.00 
1.00 
1.00 
1.00 
1.00 
1.99 (1.0-3.9)
- 
ns 
ns 
ns 
ns 
0.047
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1.5 mg/dl were associated with increased risk of DGF; 
and only over the age of 40 years, cold ischemic 
time greater than 36 hours and hypertension were 
associated with increased risk of PKF. These variables 
have been classically described as risk factors for the 
incidence of DGF and PKF.12,18,19
Age, serum creatinine and hypertension in 
deceased donors are characteristics that make up the 
definition of expanded criteria donor.12 When donor 
age is greater than 50 years and combined with other 
risk factors such as hypertension, serum creatinine 
higher than 1.5 mg/dl and vascular etiology for 
brain death, or when over 60 years alone, ranks the 
deceased donor as expanded.12 To receive a kidney 
from a deceased donor with expanded criteria is 
associated with a 70% increase in the risk of graft 
loss,12 and the higher incidence of DGF, compared 
to deceased donor transplants that do not meet this 
classification.18,19
Prolonged cold ischemia time has also been 
associated with a worse kidney graft function and 
a higher incidence of DGF.11,13,20-23 Furthermore, 
the transplants with longer cold ischemia time are 
those using kidneys from expanded criteria donors24 
- organs already associated with a higher incidence 
of DGF and PKF, regardless of the waiting time 
until transplantation. Since they are less accepted by 
transplant centers, kidneys from expanded donors 
have longer allocation times.
Interestingly, the cause of brain death did not 
appear as a risk factor associated with any of the 
outcomes assessed in this study. The cause of brain 
death is also a variable that plays a role in the main 
DGF and graft function risk assessment scores 
including DDS, DCE and KDRI,12,20,25,26 besides, even 
alone, it is associated with DGF.27 In this study, the 
high incidence of stroke as a cause of death (40%) 
may have prevented the appearance of the effects of 
this risk factor in the outcomes assessed.
Although the characteristics that confer increased 
risk for DGF and PKF already have a clear association 
with outcomes in the literature, one particular factor 
of this study was the observation that donors under 
the age of 50, who are not classified as expanded 
criteria donors, also had a greater risk of conferring 
DGF and PKF. It is possible that in Brazil, where 
approaches concerning the management of deceased 
potential donors are not standardized nor prioritized 
in emergency care or intensive care units, only very 
young donors can withstand major failures in the 
process of hemodynamic and electrolytic management 
before organ extraction, thus reducing the risk of age. 
Perhaps the inadequate management of deceased 
donors interfere negatively in organ quality, yielding 
a greater risk of the recipient developing DGF and 
PKF, even when younger donors are included.
The discussion on better hemodynamic 
management of deceased donors and strategies for 
reducing the incidence of DGF and PKF is pressing 
and becomes more important in the current context, in 
which the profile of deceased donors is changing, and 
the contribution of expanded criteria donors, and even 
donors whose hearts stopped have been increasing in 
some countries.1,2 As previously discussed, this group 
of donors is associated with increased risk of DGF and 
PKF and graft loss. Thus, strategies to improve the 
quality of donors and minimize further injury to these 
organs should be thoroughly pursued. Therefore, 
interventions aimed at improving the quality of donor 
management before the extraction of multiple organs 
have been studied.
Recently, Malinoski et al.28 studied the impact of 
completing a set of goals in the management of the 
deceased donor vis-à-vis the incidence of DGF. To 
have mean arterial pressure readings between 60 and 
100 mmHg, central venous pressure between 4 and 10 
mmHg, ejection fraction greater than 50% in lowest 
possible dose of vasopressors, blood pH between 7.30 
and 7.45, PaO2/FiO2 over 300, serum sodium between 
135 and 155 mEq/l, blood glucose less than 150 and 
urine output between 0.5 and 3 ml/kg/h, together, at 
the time of family consent, were associated with a 
lower incidence of DGF (17.3% vs. 30.1%, p 0.007). 
It is noteworthy that only 14% of donors studied met 
all the criteria at this time.
As in the present study, the study from Malinoski 
et al.28 showed that only age, serum creatinine and 
TIF were associated with higher risk of DGF. The 
authors did not analyze the risk factors for PKF, as in 
the present study.
Among the variables that were significantly 
associated with worse transplantation outcome, 
only two are modifiable and, therefore, liable to 
intervention. They are: donor creatinine level and 
cold ischemia time. Therefore, based on this study, 
we need to install measures to reduce cold ischemia 
time up to 24 hours and decrease levels of serum crea-
tinine to normal limits. The reduction in donor serum 
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creatinine implies the need for a joint action between 
the Organs and Tissues Search Service and intensive 
care physicians to optimize hydration, minimizing the 
need for vasoactive drugs, and improve water balance, 
i.e. improving the management quality of the potential 
organ donor. To reduce the average time of cold 
ischemia, agility is needed in the process of locating 
and calling the recipient as well as minimizing clinical 
and laboratory evaluation times. The investigation 
regarding HLA compatibility, even before crossmatch 
results - strategy already adopted by some transplant 
centers, can help reduce this time.
This study has limitations because it is a 
retrospective study with a long evaluation period. 
Between 1998 and 2008, there were changes in 
the approach used to manage deceased donor. 
In addition, the follow-up time of recipients is of 
only six months. This alleviates the effects of other 
complications occurring after transplantation, such 
as acute rejection or infection; however, these events 
may have influenced the outcomes, particularly the 
PKF outcome.
conclusIon
The incidence of DGF and PKF was high in this 
population, possibly due to inadequate management of 
the deceased donor. Protocols for managing these donors 
should be adopted by the hospital critical care units, to 
improve the quality of organs offered for transplantation. 
A prospective study should be performed, evaluating the 
performance of these protocols and their impact on the 
function and survival of transplanted organs.
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